ArticleCurrent therapeutic research, clinical and experimental2018

Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study.

Roya Abolfazli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.